Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach

Aouizerat, 2003, Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids, J. Lipid Res, 44, 1167, 10.1194/jlr.M200480-JLR200 Mahley, 1984, Plasma lipoproteins: apolipoprotein structure and function, J. Lipid Res, 25, 1277, 10.1016/S0022-2275(20)34443-6 Montes, 1977, Lipid metabolism in pregnancy. IV. C Apoprotein changes in very low and intermediate density lipoproteins, J. Clin. Endocrinol. Metab, 45, 1060, 10.1210/jcem-45-5-1060 Nagy, 1999, Distribution of apolipoprotein(a) isoforms in normotensive and severe preeclamptic women, J. Matern. Fetal. Med, 8, 270, 10.1002/(SICI)1520-6661(199911/12)8:6<270::AID-MFM7>3.0.CO;2-E Redman, 2007, Immunological factors and placentation: implications for preeclampsia, 103 Atkinson, 2009, An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia, J. Lipid Res, 50, 71, 10.1194/jlr.M800296-JLR200 Blumenstein, 2009, A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease, Proteomics, 9, 2929, 10.1002/pmic.200800625 Flood-Nichols, 2011, Elevated Ratio of Maternal Plasma Ratio of ApoCIII to ApoCII in Preeclampsia, Repro. Sci, 18, 493, 10.1177/1933719110390390 Levels, 2007, SELDI-TOF mass spectrometry of High-Density Lipoprotein, Proteome Sci, 5, 15, 10.1186/1477-5956-5-15 Nelsestuen, 2005, Plasma protein profiling: unique and stable features of individuals, Proteomics, 5, 4012, 10.1002/pmic.200401234 Shankar, 2004, Applications of proteomic methodologies to human pregnancy research: a growing gestation approaching delivery?, Proteomics, 4, 1909, 10.1002/pmic.200300790 Shankar, 2005, An emerging role for comprehensive proteome analysis in human pregnancy research, Reproduction, 129, 685, 10.1530/rep.1.00524 American College of Obstetrics and Gynecology, 2003, ACOG Practice Bulletin Management of Preterm Labor Bons, 2006, Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry, Clin. Chim. Acta, 366, 249, 10.1016/j.cca.2005.10.019 Bondarenko, 1999, Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein, J. Lipid Res, 40, 543, 10.1016/S0022-2275(20)32459-7 Barton, 2010, Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins, J. Proteome Res, 9, 333, 10.1021/pr900658d Kay, 2007, The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum, Rapid Commun. Mass Spectrom, 21, 2585, 10.1002/rcm.3130 Jin, 2005, Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry, Electrophoresis, 26, 2823, 10.1002/elps.200410421 Harvey, 2009, O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease, J. Proteome Res, 8, 603, 10.1021/pr800751x Hortin, 2006, The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome, Clin. Chem, 52, 1223, 10.1373/clinchem.2006.069252 Rossi, 2006, Inflammatory protein profile during systemic high dose interleukin-2 administration, Proteomics, 6, 709, 10.1002/pmic.200500004 Shteynberg, 2011, iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates, Mol. Cell. Proteomics, 10.1074/mcp.M111.007690 Haas, 2006, Optimization and use of peptide mass measurement accuracy in shotgun proteomics, Mol. Cell. Proteomics, 5, 1326, 10.1074/mcp.M500339-MCP200 Peng, 2004, Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry, J. Biol. Chem, 279, 21003, 10.1074/jbc.M400103200 Fojo, 1986, Human preproapolipoprotein C-II. Analysis of major plasma isoforms, J. Biol. Chem, 261, 9591, 10.1016/S0021-9258(18)67554-4 Hospattankar, 1984, Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects, J. Biol. Chem, 259, 318, 10.1016/S0021-9258(17)43660-X Ito, 1989, Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure, J. Lipid Res, 30, 1781, 10.1016/S0022-2275(20)38224-9 Timms, 2007, Preanalytic influence of sample handling on SELDI-TOF serum protein profiles, Clin. Chem, 53, 645, 10.1373/clinchem.2006.080101 Vorderwulbecke, 2005, Protein quantification by SELDI-TOF-MS-based ProteinChip System, Nature Methods, 2, 393, 10.1038/nmeth0505-393 Alvarez, 1996, Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women, J. Lipid Res, 37, 299, 10.1016/S0022-2275(20)37617-3 Mazurkiewicz, 1994, Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients, J. Clin. Pathol, 47, 728, 10.1136/jcp.47.8.728 Piechota, 1992, Reference ranges of lipids and apolipoproteins in pregnancy, Eur. J. Obstet. Gynecol. Reprod. Biol, 45, 27, 10.1016/0028-2243(92)90190-A Roy, 1994, Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study, Gynecol. Obstet. Invest, 38, 10, 10.1159/000292435 De Bock, 2010, Challenges for biomarker discovery in body fluids using SELDI-TOF-MS, J. Biomed. Biotechnol, 1, 10.1155/2010/906082 Niederkofler, 2003, Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins, J. Lipid Res, 44, 630, 10.1194/jlr.D200034-JLR200 Balog, 2010, Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals, Mol. Cell Proteomics, 9, 667, 10.1074/mcp.M900537-MCP200 Choolani, 2009, Proteomic technologies for prenatal diagnostics: advances and challenges ahead, Expert. Rev. Proteomics, 6, 87, 10.1586/14789450.6.1.87 Dasari, 2007, Comprehensive proteomic analysis of human cervical-vaginal fluid, J. Proteome Res, 6, 1258, 10.1021/pr0605419 Gravett, 2007, Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection, J. Proteome Res, 6, 89, 10.1021/pr060149v Michaels, 2007, Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes, J. Proteome Res, 6, 1277, 10.1021/pr060543t Nagalla, 2007, Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers, J. Proteome Res, 6, 1245, 10.1021/pr060539h Pereira, 2007, Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid, J. Proteome Res, 6, 1269, 10.1021/pr0605421 Rasanen, 2010, Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia, J. Proteome Res, 9, 4274, 10.1021/pr100198m